Achieve Life Sciences
ACHV
38 hedge funds and large institutions have $3.04M invested in Achieve Life Sciences in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 13 closing their positions.
19% less funds holding
Funds holding: 47 → 38 (-9)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
57% less capital invested
Capital invested by funds: $7.07M → $3.04M (-$4.04M)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
96% less call options, than puts
Call options by funds: $2K | Put options by funds: $46K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$166K |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$65.2K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.6K |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$55.4K |
| 5 |
Renaissance Technologies
New York
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$869K |
| 2 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$548K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$261K |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$153K |
| 5 |
SIP
Stoneridge Investment Partners
Radnor,
Pennsylvania
|
-$73K |
ACHV Hedge Fund Activity: Q1 2016 in Review
38 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2016, worth a combined $3.04M — down 57% from $7.07M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ACHV and 4 opened new positions — a net loss of 9 holders — while 11 trimmed existing stakes and 5 added.
The largest buyer was Panagora Asset Management, adding an estimated $166K. The largest seller was Allianz Asset Management, exiting entirely with an estimated $869K sold.
- 38 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2016, down from 47 in Q4 2015.
- Funds reported $3.04M of Achieve Life Sciences stock for Q1 2016, down 57% quarter-over-quarter.
- 4 funds opened new Achieve Life Sciences positions in Q1 2016 and 13 closed out, a net change of -9 holders.
- The largest Achieve Life Sciences buyer in Q1 2016 was Panagora Asset Management, an estimated $166K added.
- The largest Achieve Life Sciences seller in Q1 2016 was Allianz Asset Management, an estimated $869K sold.
Based on aggregated 13F filings for Q1 2016.